Abingdon Health strikes strategic partnership with Senzo.

Diagnostic tests manufacturer Abingdon Health has entered into a strategic partnership with lateral flow technology group Senzo.

Abingdon Health
29 April 2024 08:20:16

Source: Sharecast

Abingdon said on Monday that its deal with Senzo will see it provide contract development and manufacturing services to both it and its partners as part of an effort to enable them to develop and manufacture new rapid tests utilising its "cutting-edge ALF platform".

Financial terms of the deal were not disclosed.

Chief executive Chris Yates said: "We are really excited to be working with Senzo and supporting them in leveraging their cutting-edge lateral flow platform technology across multiple applications.

"We believe this strategic partnership agreement provides Senzo Health and its customers with access to Abingdon's best-in-class CDMO service to enable accelerated product development and time to market."

As of 1000 GMT, Abingdon shares were down 0.19% at 5.24p.

Reporting by Iain Gilbert at Sharecast.com

N/A

ISIN: N/A

Exchange: N/A

Sell:

N/A

Buy:

N/A

Change:

Date:

Prices delayed by at least 15 minutes

Compare our accounts

Whether you're looking for a Share Dealing Account, Stocks and Shares ISA or a Self-Invested Personal Pension (SIPP), we've got an account to suit your needs..

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.